Lichen Planus

    June 2009 in “ International Journal of Dermatology ”
    Julia S. Lehman, Megha M. Tollefson Md and, Lawrence E. Gibson
    Image of study
    TLDR Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.
    Lichen planus (LP) is an inflammatory condition with a prevalence of around 1% in the USA, affecting skin, mucosa, hair, and nails, and is equally distributed among genders. It is self-limited, potentially resolving within 1 month to 7 years, and is associated with hepatitis C, with the strength of this association varying by the background hepatitis C rates. LP is characterized by polygonal, violaceous papules and plaques, and can lead to scarring alopecia, particularly in the form of lichen planopilaris (LPP), which is more common in women. LP also increases the risk of cutaneous malignancy, especially in oral and genital forms. Diagnosis is made via biopsy and direct immunofluorescence testing. Treatment options include topical and systemic corticosteroids, oral retinoids, and phototherapy, with a lack of strong evidence-based recommendations due to insufficient randomized controlled trials. Other treatments used in case reports include ciclosporin, mycophenolate mofetil, and thalidomide, while nail LP remains difficult to treat and prone to relapse.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 41 results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 4 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community Clascoterone (Winlevi) Update for Canada

      in Treatment  17 upvotes 2 years ago
      Clascoterone cream was submitted for review to Health Canada in August 2022, with hopes of approval within 3-6 months. It may potentially enhance finasteride's effects for hair loss treatment.

      community He used Dutasteride for 20 years. Interview

      in Treatment  109 upvotes 1 month ago
      Dutasteride has been used for 20 years with some hair thickness improvement but no dramatic regrowth. The user also experimented with minoxidil, tretinoin, and peptides like BPC 157 for potential benefits in hair density and quality.

      community I've tried everything and my hair is still thinning

      in Chat  6 upvotes 10 months ago
      The user has tried finasteride, oral minoxidil, iron supplements, vitamin D, and vitamin B12, but their hair is still thinning after 5 years. Another user suggested trying dutasteride.

      community The Worst Hair Loss Condition You (MAY) have: LPP

      in Research/Science  43 upvotes 3 months ago
      Lichen Planopilaris (LPP) is an autoimmune condition causing permanent hair loss and fibrosis, often misdiagnosed. Treatments include pioglitazone, topical corticosteroids, anti-inflammatory medication, and Jak inhibitors.

      community scarring alopecia awareness in this community

      in Chat  33 upvotes 2 years ago
      Lichen Planopilaris (LPP), a form of permanent hair loss, which can be mistaken for seborrheic dermatitis and is characterized by scalp itching, burning, redness, and dandruff. Treatment options discussed include steroidal creams, finasteride, minoxidil, and RU58841.

    Similar Research

    5 / 1000+ results